Global Valsartan Prices Plunge Amid Weak Demand and Year-End Inventory Clearances

The decline in Valsartan prices in China can be attributed to a combination of factors, notably the softening economic conditions reflected in the country’s manufacturing sector. China&#**;s official National Bureau of Statistics (NBS) Manufacturing PMI unexpectedly dropped to **.* in December ****, signaling a slowdown after a period of expansion. Although the index still remained above the neutral ** mark, indicating slight growth, the weakening pace of factory output, which grew at its slowest rate in four months, points to underlying challenges in the manufacturing sector. The persistent weakness in foreign orders further contributed to this slowdown, reducing the demand for products such as Valsartan. With reduced activity in both domestic and international markets, manufacturers faced excess supply, which pressured Valsartan prices downward.

Given China&#**;s role as a major exporter of Active Pharmaceutical Ingredients (APIs), a similar trend in Valsartan prices emerged in both...